Merck Animal Health Introduces First and Only FDA Approved Drug for Controlling Pain in CattleWed, 31 Jan 2018 17:16:46 CST
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today introduced Banamine® Transdermal (flunixin transdermal solution) - the first and only U.S. Food & Drug Administration (FDA) approved product for pain control in a food producing animal. It is approved for the control of pain associated with foot rot and fever associated with bovine respiratory disease (BRD). Applied as a pour-on, BANAMINE TRANSDERMAL is easy to administer for pain and fever management.
“BANAMINE TRANSDERMAL is a breakthrough innovation with its patented delivery,” said Scott Bormann, vice president, North America commercial operations for Merck Animal Health. “It is the first and only non-steroidal, anti-in?ammatory (NSAID) cattle product available as a pour-on, and the latest example of Merck Animal Health’s commitment to improve animal health and well-being, and provide animal caregiver solutions that help deliver a safe, sustainable food supply.”
Merck Animal Health launched the new first-of-its-kind pharmacuetical product, on the trade show floor of the National Cattlemen's Beef Association and Cattle Industry Convention, this week in Phoenix. Radio Oklahoma Ag Network Farm Director Ron Hays caught up with Merck's National Lead on Animal Welfare Dr. Angela Baysinger, to talk about the product. You can listen to their complete conversation about it, by clicking or tapping the LISTEN BAR below at the bottom of the page.
"As everyone knows, we've never had a product specifically labelled for pain," she said. "It is the first pain product for a food producing animal. So, we're really excited about it."
The pour-on application eliminates the time-consuming and stressful treatment process associated with intravenous (IV) administration, which is the administration route of previous NSAIDs.
“Studies show that a single dose of BANAMINE TRANSDERMAL is absorbed into the bloodstream within minutes and has long duration of activity at the site of inflammation,” said Scott Nordstrom, D.V.M., associate director, scientific marketing affairs, Merck Animal Health. “This gives cattle the best opportunity to recover quickly and return to productivity.”
In field studies at four U.S. locations involving animals diagnosed with BRD, 58.3 percent of cattle treated with BANAMINE TRANSDERMAL had at least a 2-degree F drop in temperature within six hours of treatment compared to 6.1 percent for the placebo group. Significant results also were seen in two studies around pain associated with foot rot, which showed that 93.3 percent to 100 percent of cattle treated with BANAMINE TRANSDERMAL had improved lameness scores compared to 6.7 percent and 53.3 percent for the placebo groups.
“Veterinarians and producers are increasingly addressing the relationship between animal well-being and lost performance,” Dr. Nordstrom pointed out. “Pain mitigation in animals also is a growing goal across the food chain. Fever and pain can cause cattle to stop eating and drinking. BANAMINE TRANSDERMAL can help cattle feel better for a healthy and productive outcome.”
BANAMINE TRANSDERMAL is a prescription product that meets the best management practices outlined in the industry’s Beef Quality Assurance program. The pour-on application eliminates injection-site lesions within the carcass at marketing and reduces risk of residues, resulting in a higher-value end product.
The pre-calibrated packaging and red-colored solution help ensure the correct dose is given every time. The unique bottle design makes it simple to apply topically on dry skin in a narrow strip down the animal’s midline from the withers to the tail head.
To learn more about BANAMINE TRANSDERMAL, visit BanamineTD.com or contact your veterinarian.
Source - Merck Animal Health
WebReadyTM Powered by WireReady® NSI
Top Agricultural News